Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection
MinorTrial status: Active, Not Recruiting to Completed
Study completion date changed from estimate of Dec 2018 to Jun 15, 2017
v256
NotableResults first posted: Oct 2, 2017v255Show 5 more changesShow less
Primary endpoint revised
Enrollment target: estimated 877 to confirmed 568
Study completion date: Dec 2018
Secondary endpoints revised (4)
Site details revised at 2 of 76 sites
Re-verified, no change to tracked fieldsv254
MinorPrimary completion date: Jun 2015 to Nov 2015v253
Show 45 earlier versionsHide 45 earlier versions
NotablePrimary endpoint revised
Eligibility criteria revised
Secondary endpoints: details revised at 4 of 4 entries
v252
NotablePhase: Not applicable to Phase 3v251Show 11 more changesShow less
Lead sponsor: Cancer and Leukemia Group B to Alliance for Clinical Trials in Oncology
Enrollment target: 560 to 877
Primary completion date changed from estimate of Dec 2012 to Jun 2015
Primary endpoint revised
Trial status: Recruiting to Active, Not Recruiting
Interventions: assessment of therapy complications (Procedure), complementary or alternative medicine procedure (Procedure), educational intervention… to Physical therapy (Procedure), educational intervention (Other), quality of life assessment (Other)
Eligibility criteria expanded, about 115 words
Secondary endpoints revised (4)
Study description shortened, about 135 words
Study sites revised (76)
Study arms: 0 to 2
MinorStudy sites: 77 to 76v250
MinorStudy sites: 78 to 77v249
MinorStudy sites: 76 to 78v248
MinorStudy sites: 75 to 76v247
MinorStudy sites: 74 to 75v246
MinorStudy sites: 75 to 74v245
MinorStudy sites: 76 to 75v244
Re-verified, no change to tracked fieldsv243
MinorStudy sites: 75 to 76v242
MinorStudy sites revised (75)v241
Re-verified, no change to tracked fieldsv240
MinorStudy sites: 74 to 75v239
Re-verified, no change to tracked fieldsv238
MinorStudy sites: 76 to 74v237
MinorStudy sites: 75 to 76v236
MinorStudy sites: 77 to 75v235
Re-verified, no change to tracked fieldsv234
MinorSite contacts updated at 1 of 77 sitesv233
MinorStudy sites: 76 to 77v232
MinorStudy sites: 75 to 76v231
MinorStudy sites: 76 to 75v230
MinorStudy sites: 77 to 76v229
MinorSite details revised at 1 of 77 sitesv228
Re-verified, no change to tracked fieldsv227
MinorStudy sites: 76 to 77v226
MinorStudy sites: 71 to 76v225
MinorStudy sites: 51 to 71v224
MinorStudy sites: 50 to 51v223
MinorStudy sites: 49 to 50v222
MinorStudy sites: 50 to 49v221
MinorStudy sites: 69 to 50v220
MinorStudy sites: 77 to 69v219
MinorStudy sites: 78 to 77v218
MinorStudy sites: 77 to 78v217
MinorStudy sites: 73 to 77v216
MinorStudy sites: 75 to 73v215
MinorStudy sites: 76 to 75v214
MinorStudy sites: 77 to 76v213
MinorStudy sites: 78 to 77v212
MinorStudy sites: 79 to 78v211
MinorStudy sites: 78 to 79v210
MinorStudy sites: 77 to 78v209
MinorStudy sites: 76 to 77v208
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This randomized phase III trial studies how well education with or without physical therapy intervention works in preventing lymphedema in women with stage I, II, or III breast cancer who are undergoing axillary lymph node dissection (surgery to remove lymph nodes found in the armpit region). Lymphedema is a condition in which extra lymph fluid builds up in tissues and causes swelling in an arm or leg if lymph vessels are blocked, damaged, or removed by surgery. A personalized physical therapy intervention and education materials may be better than education materials alone in preventing lymphedema in women with breast cancer who are undergoing axillary lymph node dissection.